RegAsk Secures Venture Capital Funding to Secure Growth
Summary
The financing allows the RegTech firm to carry out its ambitious growth strategy, and its product development plan.With the increasing complexity of regulatory standards, companies are forced to exhaust resources to stay competitive in markets around the world, said Caroline Shleifer, president of RegAsks Board of Directors. Our platform revolutionizes the process for our customers, using a unique approach in providing proprietary, dynamic data with more efficient research, analysis and monitoring technologies.RegAsk offers a full scope of regulatory services including compliance, path-to-market, path-to-claim, product registration and regulatory strategy for the food, dietary supplement, cosmetic, personal care and medical device industries. TKS1 provides early stage capital to innovative companies offering solutions that move science forward in the health sector, contribute to the transition from intervention to prediction, diagnosis and monitoring while enabling life science companies globally to develop therapeutics faster and more economically.SPRIM is a life-science consulting agency for the full lifecycle of a product. Multi-nationals, startups, institutions and governments around the world turn to SPRIM for expertise in developing relevant, fresh and meaningful health innovations. Controlled by its managers, alongside leading institutional partners, Tikehau Capital employs 260 staff (as at 30 September 2018) in its Paris, London, Brussels, Madrid, Milan, New York, Seoul and Singapore offices.RegAsk is a digital platform that automates regulatory research and compliance strategy for the food, dietary supplement, cosmetic, personal care and medical device industries.